Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
Sankamap Secures Two-Year Prospecting Licence Renewals for District-Scale Kuma and Fauro Copper Gold Properties
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT